MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
Telix Pharmaceuticals share price in focus as China’s NMPA accepts Illuccix NDA for prostate cancer imaging, marking a ...
Q. You recently wrote that testosterone does not increase the risks for heart attacks. But you overlooked the real risk of testosterone therapy: cancer!
Experts called for urgent action to tackle air pollution after evidence suggested traffic and industrial fumes may contribute ...
After becoming a patient himself following a recent cancer diagnosis, a local doctor said he wants to share his story to ...
Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...
Health and Me on MSN
NHS England expands access to life-saving prostate cancer drug
NHS England has expanded access to the prostate cancer drug abiraterone after patient and charity campaigning. Previously ...
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...
Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results